Home LiteratureArticle Details
PMID: 26014592 Published · ppublish English Journal Article

The FDA and genomic tests--getting regulation right.

The New England journal of medicine ·Vol. 372 ·No. 23 ·2015-06-04 ·Pages 2258-64

Evans BJ, Burke W, Jarvik GP

Abstract

暂无摘要

MeSH Terms
Genetic Techniques/standards Genetic Testing/legislation & jurisprudence,standards Genome-Wide Association Study Genomics Genotyping Techniques Government Regulation Guidelines as Topic High-Throughput Nucleotide Sequencing/standards Humans United States United States Food and Drug Administration
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Evans Barbara J
From the Center for Biotechnology and Law, University of Houston Law Center, Houston (B.J.E.); and the Departments of Bioethics and Humanities (W.B.), Medicine (Medical Genetics) (G.P.J.), and Genome Sciences (G.P.J.), University of Washington, Seattle.
Burke Wylie
Jarvik Gail P
References (10)
10 references, click to expand
  1. A new initiative on precision medicine.
    N Engl J Med. 2015 Feb 26;372(9):793-5 PMID: 25635347
  2. CLIA program and HIPAA privacy rule; patients' access to test reports. Final rule.
    Fed Regist. 2014 Feb 6;79(25):7289-316 PMID: 24605389
  3. Taxonomizing, sizing, and overcoming the incidentalome.
    Genet Med. 2012 Apr;14(4):399-404 PMID: 22323072
  4. ACMG clinical laboratory standards for next-generation sequencing.
    Genet Med. 2013 Sep;15(9):733-47 PMID: 23887774
  5. Actionable, pathogenic incidental findings in 1,000 participants' exomes.
    Am J Hum Genet. 2013 Oct 3;93(4):631-40 PMID: 24055113
  6. Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine.
    JAMA. 2015 Feb 17;313(7):669-70 PMID: 25560537
  7. Clinical interpretation and implications of whole-genome sequencing.
    JAMA. 2014 Mar 12;311(10):1035-45 PMID: 24618965
  8. Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes.
    Genet Med. 2014 Jul;16(7):529-34 PMID: 24357849
  9. Development of the clinical next-generation sequencing industry in a shifting policy climate.
    Nat Biotechnol. 2014 Oct;32(10):980-2 PMID: 25299915
  10. FDA regulation of laboratory-developed diagnostic tests: protect the public, advance the science.
    JAMA. 2015 Feb 17;313(7):667-8 PMID: 25560381
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJMsr1501194
Published
2015-06-04
Epub
2015-00-27
Pages
2258-64
Language
English
Region
United States
NLM ID
0255562
PMCID
PMC4464691
Subset
IM
Grants
NHGRI NIH HHS · U01 HG006507 · United States
NHGRI NIH HHS · U01 HG007307 · United States
Corrections
CommentIn
PMID: 26014594
External Links
PubMed source DOI: 10.1056/NEJMsr1501194 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2